Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Oct;27(5):437-43.
doi: 10.1097/QCO.0000000000000094.

Norovirus in healthcare settings

Affiliations
Free PMC article
Review

Norovirus in healthcare settings

Miren Iturriza-Gómara et al. Curr Opin Infect Dis. 2014 Oct.
Free PMC article

Abstract

Purpose of review: To provide an overview of the burden of norovirus disease in healthcare settings and the factors responsible for outbreaks in these institutions; to assess progress on interventions aimed at reducing the burden of norovirus disease.

Recent findings: Norovirus outbreaks in healthcare settings are driven by confluence of viral diversity, the built environment, and host factors. Some of these characteristics may be modifiable and the target of successful interventions.

Summary: Most norovirus outbreaks in hospital and residential care institutions are associated with a particular genotype, known as GII.4. The persistence of norovirus is associated with strain diversity, which is driven by immune evasion and viral adaptation to interaction with a variety of human histo-blood group antigens. The healthcare environment presents serious challenges for control, both because of the physical structure of the built space and the high levels of contact among patient populations who may have compromised hygiene. Increased vulnerability among the populations in healthcare institutions is likely to be multifactorial and may include the following: nutritional status, immunodeficiency or senescence, chronic inflammation, and microbiome alterations. Current control measures are based on general infection control principles, and treatment is mainly supportive and nonspecific. Vaccines and antiviral agents are being developed with promising results, but none are currently available.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Interrelationships among the main drivers of healthcare associated norovirus outbreaks and potential intervention points.
Box 1
Box 1
no caption available

Similar articles

Cited by

References

    1. Hall AJ, Lopman BA, Payne DC, et al. Norovirus disease in the United States. Emerg Infect Dis 2013; 19:1198–1205 - PMC - PubMed
    1. Tam CC, Rodrigues LC, Viviani L, et al. Longitudinal study of infectious intestinal disease in the UK (IID2 study): incidence in the community and presenting to general practice. Gut 2012; 61:69–77 - PMC - PubMed
    1. Gastanaduy PA, Hall AJ, Curns AT, et al. Burden of norovirus gastroenteritis in the ambulatory setting – United States, 2001–2009. J Infect Dis 2013; 207:1058–1065 - PubMed
    1. Lopman BA, Reacher MH, Vipond IB, et al. Epidemiology and cost of nosocomial gastroenteritis, Avon, England, 2002–2003. Emerg Infect Dis 2004; 10:1827–1834 - PMC - PubMed
    1. Payne DC, Vinje J, Szilagyi PG, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med 2013; 368:1121–1130 - PMC - PubMed
    2. This article demonstrates that after the introduction of rotavirus vaccination programs, norovirus has become the main cause of moderate-to-severe pediatric gastroenteritis in the United States. This is an important reminder for those countries in which vaccines are being rolled as norovirus infection are rarely investigated in paediatric or sporadic cases of gastroenteritis.

MeSH terms